Paris, France, December 1st, 2016—BIOMILLENIA was selected as winner of the “Pitch Your Microbes” competition by the jury members at the European Microbiome Congress.
The prize gives BIOMILLENIA access to the Johnson & Johnson Innovation JLINX facility. “This special recognition is a great support from the experts in the field valuing BIOMILLENIA’s unique capabilities for the discovery and development of non-GMO microbial strains. Our technology not only has unprecedented capabilities to culture and screen millions of strain variants in parallel in very short turnaround time, but also to access a much broader variety of species from the so-called “unculturable microbiome”. This has become an important key to unlock nature’s potential for the research and development of products in the field of probiotics and other markets that rely on the development of non-GMO strains and natural ingredients,” said Dr. Dirk Loeffert, President of BIOMILLENIA.
BIOMILLENIA is a leading company for the development of production strains and enzymes. Its unique technology platform delivers novel bacterial, fungal or yeast strain properties and enzymes for the manufacture of chemicals and natural products at throughputs and speeds several orders of magnitudes higher than with traditional methods. BIOMILLENIA “Unlocks Nature’s Potential” for cost-competitive and sustainably manufactured novel biology-based products for a better life.